Open AccessP18: DARATUMUMAB (D) PLUS BORTEZOMIB (V) AND DEXAMETHASONE (D) AS SALVAGE THERAPY FOR PATIENTS WITH REFRACTORY/RELAPSED MULTIPLE MYELOMA (RRMM): INITIAL FOLLOW‐UP OF AN ITALIAN MULTICENTER RETROSPECTIVE CLINICAL EXPERIENCE BY “RETE EMATOLOGICA PUGLIESE”
Author(s) -
Mele G,
Cascavilla N,
Di Renzo N,
Guarini A,
Mazza P,
Melillo L,
Pavone V,
Tarantini G,
Curci P,
Falcone AP,
Germano C,
Mele A,
Palazzo G,
Palumbo G,
Reddiconto G,
Rossini B,
Specchia G,
Musto P,
Pastore D
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000829644.33207.9c
Subject(s) - medicine , salvage therapy , neutropenia , carfilzomib , regimen , bortezomib , lenalidomide , multiple myeloma , surgery , retrospective cohort study , refractory (planetary science) , chemotherapy , physics , astrobiology